CRP (C-reactive protein) is a well-established biomarker of systemic inflammation, produced by the liver in response to interleukin-6. Gut health—particularly the composition of the microbiome and the integrity of the intestinal barrier—can influence systemic inflammatory load. Dysbiosis with overgrowth of potentially pathogenic bacteria and increased intestinal permeability ("leaky gut") may allow endotoxins like lipopolysaccharides (LPS) to enter the bloodstream, triggering an immune response and raising CRP levels. Clinical studies show that individuals with inflammatory bowel disease (IBD) or irritable bowel syndrome often have elevated CRP. However, CRP is non-specific: infections, obesity, smoking, or rheumatic diseases can also raise it. Dietary interventions such as fiber, probiotics, or omega-3 fatty acids can positively modulate the gut flora and lower CRP, but the evidence is moderate and not uniform across individuals. A MyBody-X test measures CRP in blood, not gut health directly. Combining it with stool microbiome analysis or genetic markers (e.g., IL6 polymorphisms) may provide a more comprehensive picture, but remains interpretive. Bottom line: CRP and gut health are linked via inflammatory pathways, but the relationship is multifactorial and not causally proven. Elevated CRP should always be evaluated by a physician.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-3d2d6243fc36a803108e248c